Minimizing Preanalytical Variation of Plasma Samples by Proper Blood Collection and Handling

Methods in Molecular Biology

Volumn 728, Issue , 2011, Pages 137-149

  Yi, Jizu ^a   Craft, David ^b   Gelfand, Craig A ^b  

^a BD Technologies   (United States)

^b NONE

Author keywords

Blood collection; Intrinsic proteolysis; MALDI TOF MS; Peptide analysis; Plasma peptidomics; Plasma preparation; Preanalytical variability

Indexed keywords

PEPTIDE;

ARTICLE; BLOOD; BLOOD SAMPLING; CHEMISTRY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; PLASMA;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; HUMANS; PEPTIDES; PLASMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79960115783     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-068-3_8     Document Type: Chapter

References (27)

1. Omenn, G. S. (2004) Advancement of biomarker discovery and validation through the HUPO plasma proteome project, Disease Markers 20, 131–134.
2. Anderson, N. L., Anderson, N. G. (2002) The human plasma proteome-History, character, and diagnostics preospects, Mol. Cell. Proteomics 1, 845–867.
3. Yi, J., Kim, C., and Gelfand, C. A. (2007) Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma, J Proteome Res 6, 1768–1781.
4. Rai, A. J., Gelfand, C. A., Haywood, B. C. et al. (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples, Proteomics 5, 3262–3277.
5. West-Nielsen, M., Høgdall, E. V., Marchiori, E., et al. (2005) Sample Handling for Mass Spectrometric Proteomic Investigations of Human Sera, Analy Chem 77, 5114–5123.
6. Bowen, R. A., Hotin, G., Csako, G., et al. (2010) Impact of blood collection devices on clinical chemistry assays., Clin Biochem, 43, 4–25.
7. Yi, J., Liu, Z., Craft, D., et al. (2008) Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides, J Proteome Res 7, 5112–5118.
8. Findeisen, P., Peccerella, T., Post, S,, et al. (2008) Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool, Rapid Commun Mass Spectrom 22, 1223–1230.
9. Villanueva, J, Nazarian, A., Lawlor, K., Yi, S. S., Robbins, R. J., Tempst, P. (2008) A sequence-specific exopeptidase activity test (SSEAT) for “functional” biomarker discovery, Mol Cell Proteomics 7, 509–518.
10. Petricoin, E. F., Belluco, C., Araujo, R. P., and Liotta, L. A. (2006) The blood peptidome: a higher dimension of information content for cancer biomarker discovery, Nature Reviews. Cancer 6, 961–967.
11. Villanueva, J., Shaffer, D. R., Philip, J. et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns, Journal of Clinical Investigation 116, 271–284.
12. Bensalah, K, Lotan, Y., Karam, J. A., Shariat, S. F. (2008) New circulating biomarkers for prostate cancer, Prostate Cancer Prostatic Dis 11, 112–121.
13. Bierhaus, A., and Nawroth, P. P. (2005) Posttranslational modification of lipoproteins – A fatal attraction in metabolic disease?: Commentary on: Hone et al., Alzheimer’s disease amyloid-beta peptide modulates apo-lipoprotein E isoform specific receptor binding, Journal of Alzheimer’s Disease 7, 315–317.
14. Elbatarny, H. S., Netherton, S. J., Ovens, J. D., Ferguson, A. V., and Maurice, D. H. (2007) Adiponectin, ghrelin, and leptin dif-ferentially influence human platelet and human vascular endothelial cell functions: implication in obesity-associated cardiovascular diseases, Eur J Pharmacol 558, 7–13.
15. Lorenzo, O., Martín-Ventura, J. L., Blanco-Colio, L. M., et al. (2009) The proteomic approach in the development of prognostic biomarkers in atherothrombosis. Recent Pat Cardiovasc Drug Discov 4, 25-31.
16. Fu, Q, Van Eyk, J. E. (2006) Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics 3, 237–250.
17. Mitchell, B. L., Yasui, Y., Li, C. I., et al. (2005) Impact of Freeze-thaw Cycles and Storage Time on Plasma Samples Used in Mass Spectrometry Based Biomarker Discovery Projects, Cancer Informatics 1, 98–104.
18. Hsieh, S.-Y., Chen, R.-K., Pan, Y.-H., and Lee, H.-L. (2006) Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling, Proteomics 6, 3189–3198.
19. Craft, D., Yi, J., and Gelfand, C. A. (2009) Time-Dependent and Sample-to-Sample Variations in Human Plasma Peptidome are Both Minimized Through Use of Protease Inhibitors, Analytical Letters 42, 1398–1406.
20. Yi, J, Liu, Z. X., Gelfand C. A, Craft, D. (2011) Investigation of Peptide Biomarker Stability in Plasma Sample using Time-course MS Analysis, Ed. Simpson Richard J, Greening David, Serum/Plasma Proteomics: Method and Protocols. Humana Press.
21. O’Mullan, P., Craft, D., Yi, J., and Gelfand, C. A. (2009) Thrombin induces broad spectrum proteolysis in human serum samples, Clin Chem Lab Med. 47, 685–697.
22. Tammen, H., Schulte, I., Hess, R. et al. (2005) Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display, Proteomics 5, 3414–3422.
23. Guder W G, N. S., Wilsser H, Zawta B. (1996) Samples: From the Patient to the Laboratory GIT VERLAG.
24. Slichter, S. J. (1978) Preservation of platelet viability and function during storage of concentrates., Prog Clin Biol Res 28, 83–101.
25. Ayukawa, O., Nakamura, K., Kariyazono, H. et al. (2009) Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation, Blood Coagul Fibrinolysis 20, 176–185.
26. Gulliksson, H., van der Meer, P. F. (2009) Storage of whole blood overnight in dif ferent blood bags preceding preparation of blood components: in vitro ef fects on red blood cells., Blood Transfus 7, 210–235.
27. Rossignol, P., Cambillau, M. l., Bissery, A. et al. (2008) Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors. Clinical & Experimental Pharmacology & Physiology 35, 464–469.